Ceapro Inc. — Investor Relations & Filings
Ceapro Inc. is a biotechnology company specializing in the development and commercialization of natural-based active ingredients derived primarily from oats and other renewable sources. The company utilizes proprietary extraction technology to produce high-value compounds, including Oat Beta Glucan, Oat Avenanthramides, and Oat Oil. These ingredients are engineered for applications across multiple sectors. Key markets include cosmeceuticals (for skin barrier function, hydration, and anti-aging), nutraceuticals (for cholesterol management and gut health), and pharmaceuticals (currently developing anti-inflammatory treatments). The company's unique focus is on combining the simplicity of nature with scientific innovation to deliver solutions that improve global health and wellness.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Notice.pdf | 2024-06-06 | English | |
| Material change report - English.pdf | 2024-06-06 | English | |
| News release - English.pdf | 2024-06-03 | English | |
| News release - English.pdf | 2024-02-26 | English | |
| News release - English.pdf | 2024-02-26 | English | |
| News release - English.pdf | 2024-02-23 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 30201774 | Notice.pdf | 2024-06-06 | English | ||
| 30201783 | Material change report - English.pdf | 2024-06-06 | English | ||
| 30156344 | News release - English.pdf | 2024-06-03 | English | ||
| 29581318 | News release - English.pdf | 2024-02-26 | English | ||
| 29581396 | News release - English.pdf | 2024-02-26 | English | ||
| 13721927 | News release - English.pdf | 2024-02-23 | English | ||
| 13720193 | News release - English.pdf | 2024-02-15 | English | ||
| 13720198 | News release - English.pdf | 2024-02-15 | English | ||
| 13720230 | Other material contracts - English.pdf | 2024-02-15 | English | ||
| 13720229 | Other material contracts - English.pdf | 2024-02-15 | English | ||
| 13720242 | Notice of meeting - English.pdf | 2024-02-15 | English | ||
| 13720241 | Other.pdf | 2024-02-15 | English | ||
| 13720239 | Form of proxy - French.pdf | 2024-02-15 | English | ||
| 13720238 | Form of proxy - English.pdf | 2024-02-15 | English | ||
| 13720237 | Management information circular - English.pdf | 2024-02-15 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
Ceapro Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/44617/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=44617 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=44617 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=44617 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 44617}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ceapro Inc. (id: 44617)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.